UiPath Stock Forecast, Price & News

UiPath (NASDAQ:PATH) Frequently Asked Questions

Is UiPath a buy right now?

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last year. There are currently 2 sell ratings, 11 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" UiPath stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View analyst ratings for UiPath or view top-rated stocks.

How has UiPath's stock been impacted by COVID-19 (Coronavirus)?

UiPath's stock was trading at $18.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PATH stock has increased by 166.2% and is now trading at $47.92.
View which stocks have been most impacted by COVID-19.

When is UiPath's next earnings date?

UiPath is scheduled to release its next quarterly earnings announcement on Wednesday, December 8th 2021.
View our earnings forecast for UiPath.

How can I listen to UiPath's earnings call?

UiPath will be holding an earnings conference call on Wednesday, December 8th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415.

How were UiPath's earnings last quarter?

UiPath Inc. (NASDAQ:PATH) posted its quarterly earnings results on Monday, September, 6th. The healthcare company reported $0.01 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.05) by $0.06. The healthcare company had revenue of $195.52 million for the quarter, compared to the consensus estimate of $186.72 million. The business's quarterly revenue was up 40.3% compared to the same quarter last year.
View UiPath's earnings history.

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its third quarter 2022 earnings guidance on Tuesday, October, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $207 million-$209 million, compared to the consensus revenue estimate of $206.17 million.

What price target have analysts set for PATH?

23 analysts have issued 12 month target prices for UiPath's shares. Their forecasts range from $40.00 to $86.00. On average, they expect UiPath's stock price to reach $71.00 in the next twelve months. This suggests a possible upside of 48.2% from the stock's current price.
View analysts' price targets for UiPath or view top-rated stocks among Wall Street analysts.

Who are UiPath's key executives?

UiPath's management team includes the following people:

• Mr. Daniel Solomon Dines, Co-Founder, CEO, & Chairman (Age 49)
• Mr. Marius Tirca, Co-Founder & CTO
• Mr. Ashim Gupta, Chief Financial Officer (Age 42) (LinkedIn Profile)
• Mr. Brad C. Brubaker, Gen. Counsel, Chief Legal Officer & Sec. (Age 57) (LinkedIn Profile)
• Mr. Robert B. Patrick, Chief Marketing Officer (Age 49)
• Mr. Christopher Townsend, VP of Federal Sales
• Mr. Vijay Khanna, Chief Corp. Devel. Officer
• Ms. Bettina H. Koblick, Chief People Officer (Age 55)
• Mr. Vargha Moayed, Chief Strategy Officer
• Mr. Chris Klayko, Sr. VP & MD of Americas

Who are some of UiPath's key competitors?

Some companies that are related to UiPath include Square (SQ), Dassault Systèmes (DASTY), NetEase (NTES), Roblox (RBLX), Cloudflare (NET), Autodesk (ADSK), Datadog (DDOG), Synopsys (SNPS), Atlassian (TEAM), Twilio (TWLO), CrowdStrike (CRWD), Cadence Design Systems (CDNS), Unity Software (U), VMware (VMW) and DocuSign (DOCU).
View all of PATH's competitors.

What other stocks do shareholders of UiPath own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UiPath investors own include Amyris (AMRS), Alpha Natural Resources (ANRZQ), Aralez Pharmaceuticals (ARLZ), Arena Pharmaceuticals (ARNA), BlackBerry (BB), Ballard Power Systems (BLDP), Central European Media Enterprises (CETV), Canadian Solar (CSIQ), FuelCell Energy (FCEL) and Glu Mobile (GLUU).

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering (IPO) on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the NASDAQ under the ticker symbol "PATH."

When did the company's lock-up period expire?

UiPath's lock-up period expired on Monday, October 18th. UiPath had issued 23,890,777 shares in its public offering on April 21st. The total size of the offering was $1,337,883,512 based on an initial share price of $56.00. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Who are UiPath's major shareholders?

UiPath's stock is owned by a variety of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (2.75%), Nikko Asset Management Americas Inc. (2.74%), Wellington Management Group LLP (0.79%), Allianz Asset Management GmbH (0.75%), Sands Capital Ventures LLC (0.74%) and Goldman Sachs Group Inc. (0.73%). Company insiders that own UiPath stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends for UiPath.

Which major investors are selling UiPath stock?

PATH stock was sold by a variety of institutional investors in the last quarter, including Dragoneer Investment Group LLC, Disruptive Technology Advisers LLC, Sands Capital Management LLC, Madrona Venture Group LLC, Sculptor Capital LP, Citigroup Inc., Allianz Asset Management GmbH, and Squarepoint Ops LLC. Company insiders that have sold UiPath company stock in the last year include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert, and Thomas Neergaard Hansen.
View insider buying and selling activity for UiPath or view top insider-selling stocks.

Which major investors are buying UiPath stock?

PATH stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Sands Capital Ventures LLC, BlackRock Inc., Geode Capital Management LLC, StepStone Group LP, Eagle Asset Management Inc., and Portman Ltd.
View insider buying and selling activity for UiPath or or view top insider-buying stocks.

How do I buy shares of UiPath?

Shares of PATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $47.92.

How much money does UiPath make?

UiPath has a market capitalization of $24.61 billion.

How many employees does UiPath have?

UiPath employs 2,863 workers across the globe.

Does UiPath have any subsidiaries?

The following companies are subsidiares of UiPath: Magna View BV, Process Gold International BV, ProcessGold, StepShot, UiPath AB, UiPath Australia Pty Ltd, UiPath Canada, UiPath China - Shanghai, UiPath France SAS, UiPath GMBH, UiPath Hong Kong, UiPath KK, UiPath Limited, UiPath Ltd. (India), UiPath Ltd. (SG), UiPath Ltd. (UK), UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath SRL, UiPath South Korea, and UiPath Switzerland GmbH.

When was UiPath founded?

UiPath was founded in 2005.

What is UiPath's official website?

The official website for UiPath is www.nupathe.com.

Where are UiPath's headquarters?

UiPath is headquartered at 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States.

How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company can be reached via phone at 844-432-0455 or via email at [email protected].